Cytokine activation induces human memory-like NK cells

Blood

Volumn 120, Issue 24, 2012, Pages 4751-4760

  Romee, Rizwan ^a   Schneider, Stephanie E ^a   Leong, Jeffrey W ^a   Chase, Julie M ^a   Keppel, Catherine R ^a   Sullivan, Ryan P ^a   Cooper, Megan A ^a   Fehniger, Todd A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; CD57 ANTIGEN; CD69 ANTIGEN; CD94 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; LYMPHOCYTE RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR NKG2C; PROTEIN; PROTEIN KIR; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CELL STRAIN K 562; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; HUMAN; HUMAN CELL; MEMORY CELL; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84870736330     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-04-419283     Document Type: Article

References (32)

1. Caligiuri MA. Human natural killer cells. Blood. 2008;112(3):461-469.
2. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol. 2008;9(5):503-510. (Pubitemid 351560519)
3. Jonsson HA, Yokoyama WM. Natural killer cell tolerance licensing and other mechanisms. Adv Immunol. 2009;101(08):27-79.
4. Lanier LL. Evolutionary struggles between NK cells and viruses. Nat Rev Immunol. 2008;8(4):259-268. (Pubitemid 351432802)
5. Di Santo JP. Natural killer cells: diversity in search of a niche. Nat Immunol. 2008;9(5):473-475. (Pubitemid 351560514)
6. Cooper MA, Elliott JM, Keyel PA, et al. Cytokine-induced memory-like natural killer cells. Proc Natl Acad Sci U S A. 2009;106(6):1915-1919.
7. Sun JC, Beilke JN, Lanier LL. Adaptive immune features of natural killer cells. Nature. 2009;457(7229):557-561.
8. O'Leary JG, Goodarzi M, Drayton DL, Yu H, von Andrian UH. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol. 2006;7(5):507-516.
9. Paust S, Gill HS, Wang B-Z, et al. Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat Immunol. 2010;11(12):1127-1135.
10. Gumá M, Angulo A, Vilches C, et al. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood. 2004;104(12):3664-3671. (Pubitemid 39564443)
11. Gumá M, Budt M, Sáez A, et al. Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood. 2006;107(9):3624-3631.
12. Björkström NK, Lindgren T, Stoltz M, et al. Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J Exp Med. 2011;208(1):13-21.
13. Petitdemange C, Becquart P, Wauquier N, et al. Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity. PLoS Pathogens. 2011;7(9):e1002268.
14. Lopez-Verges S, Milush JM, Schwartz BS, et al. Expansion of a unique CD57+NKG2C high natural killer cell subset during acute human cytomegalovirus infection. Proc Natl Acad Sci U S A. 2011;108(36):
15. Foley B, Cooley S, Verneris MR, et al. Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function. Blood. 2012;119(11):2665-2674.
16. Sullivan RP, Leong JW, Schneider SE, et al. MicroRNA deficient NK cells exhibit decreased survival but enhanced function. J Immunol. 2012;188(7):3019-3030.
17. White DW, Keppel CR, Schneider SE, et al. Latent herpesvirus infection arms NK cells. Blood. 2010;115(22):4377-4383.
18. Martin MG, Welch JS, Uy GL, et al. Limited engraftment of low-risk myelodysplastic syndrome cells in nod/scid gamma-c chain knockout mice. Leukemia. 2010;24(9):1662-1664.
19. Alter G, Malenfant JM, Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods. 2004;294(1-2):15-22. (Pubitemid 39626587)
20. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol. 2001;22(11):633-640. (Pubitemid 33043908)
21. Cooper MA, Colonna M, Yokoyama WM. Hidden talents of natural killers: NK cells in innate and adaptive immunity. EMBO Reports. 2009;10(10):1103-1110.
22. Yu J, Mao HC, Wei M, et al. CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human nk-cell subsets. Blood. 2010;115(2):274-281.
23. Sun JC, Madera S, Bezman N a, et al. Proinflammatory cytokine signaling required for the generation of natural killer cell memory. J Exp Med. 2012;209(5):947-954.
24. Freud AG, Caligiuri M a. Human natural killer cell development. Immunol Rev. 2006;214:56-72. (Pubitemid 44707902)
25. Lopez-Vergès S, Milush JM, Pandey S, et al. CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ nk-cell subset. Blood. 2010;116(19):3865-3874.
26. Béziat V, Descours B, Parizot C, Debré P, Vieillard V. Nk cell terminal differentiation: correlated step-wise decrease of nkg2a and acquisition of kirs. PloS One. 2010;5(8):e11966.
27. Björkström NK, Riese P, Heuts F, et al. Expression patterns of NKG2A, KIR, and CD57 define a process of cd56dim NK-cell differentiation uncoupled from NK-cell education. Blood. 2010;116(19):3853-3864.
28. Young HR. Regulation of interferon-gamma gene expression. J Interferon Cytokine Res. 1996;16(8):563-568.
29. Ma F, Xu S, Liu X, et al. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ. Nat Immunol. 2011;12:861-869.
30. Ljunggren H-G, Malmberg K-J. Prospects for the use of NK cells in immunotherapy of human cancer. Nat Rev Immunol. 2007;7(5):329-339. (Pubitemid 46674487)
31. Miller JS, Soignier Y, Panoskaltsis-Mortari A, et al. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood. 2005;105(8):3051-3057.
32. Gill S, Vasey AE, De Souza A, et al. Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells. Blood. 2012;119(24):5758-5768.